Listing 1 - 10 of 34 | << page >> |
Sort by
|
Choose an application
BACKGROUND: 1. Complementary feeding is the process that starts when human milk or infant formula is complemented by other foods and beverages, beginning during infancy and typically continuing to 24 months of age.2. This systematic review was conducted by a team of Nutrition Evidence Systematic Review (NESR) staff as part of the U.S. Department of Agriculture and Department of Health and Human Services Pregnancy and Birth to 24 Months Project.3. The goal of this systematic review was to answer the following research question: What is the relationship between timing of introduction of complementary foods/beverages and food allergy, atopic dermatitis/eczema, asthma, and allergic rhinitis? CONCLUSION STATEMENT AND GRADES: 1. Moderate evidence suggests that there is no relationship between the age at which complementary feeding first begins and risk of developing food allergy, atopic dermatitis/eczema, or asthma during childhood. Grade: Moderate2. There is insufficient evidence to determine the relationship between the age at which complementary foods or beverages are first introduced and risk of developing allergic rhinitis during childhood. Grade: Grade Not Assignable METHODS: 1. This systematic review was conducted by a team of staff from NESR in collaboration with a Technical Expert Collaborative.2. A literature search was conducted using 4 databases (CINAHL, Cochrane, Embase, and PubMed) to identify articles published from January 1980 to February 2017 that examined the age when complementary foods and beverages (CFB) were first introduced and food allergy, atopic dermatitis/eczema, asthma, and allergic rhinitis. CFB were defined as foods and beverages other than human milk or infant formula provided to an infant or young child. Outcomes included incidence and prevalence of food allergy, atopic dermatitis/eczema, asthma, and allergic rhinitis. A manual search was done to identify articles that may not have been included in the electronic databases searched. Articles were screened in a dual manner, independently by 2 NESR analysts, to determine which articles met predetermined criteria for inclusion.3. Data from each included article were extracted, risk of bias was assessed. The body of evidence was qualitatively synthesized, a conclusion statement was developed and the strength of the evidence (grade) was assessed using pre-established criteria including evaluation of the internal validity/risk of bias, adequacy, consistency, impact, and generalizability of available evidence. Research recommendations were identified. SUMMARY OF EVIDENCE: 1. Thirty-one observational studies are included in this systematic review, having examined the relationship between the age of first introduction to a CFB and risk of food allergies, atopic dermatitis/eczema, asthma, and allergic rhinitis occurring during childhood through 18 years of age. ○ The studies included in this review examined the timing of introduction to CFB, or the age at which infants were first introduced to any foods or beverages other than human milk or infant formula were first introduced to an infant. (Note: Studies that examined the timing of introduction of specific types of CFB, including common allergenic foods, such as peanuts, eggs, and fish, are addressed in a separate review).○ These studies did not specify what food or beverage was first introduced. However, highly allergenic foods are not typically the first CFB introduced into an infant's diet; therefore, it is likely that the studies in this body of evidence reflect the first introduction of cereals, fruits, and vegetables.○ Nine studies examined risk of food allergy, 20 studies examined risk of eczema or atopic dermatitis, eight studies examined risk of asthma, and four studies examined risk of allergic rhinitis.2. Most evidence reported no significant associations between age of CFB introduction and risk of food allergy. While some evidence suggested that earlier first introduction of CFB may be associated with increased risk of developing food allergy, confidence in the results was restricted by methodological limitations.3. The ability to draw stronger conclusions about the relationship between the timing of first introduction to CFB and the risk of atopic disease is due to several limitations: ○ Use of non-validated or unreliable measures to assess risk of atopic disease (e.g., parent report of a physician diagnosis or the child's symptoms), and assessment of outcomes later in childhood (through 10 years of age), when some atopic diseases, such as eczema, may have already resolved, or very early in childhood (3-4 months), before some atopic diseases may have occurred.○ Lack of adjustment for key confounders such as consumption of human milk and/or human milk substitutes (e.g., cow's milk formula, hydrolyzed infant formula, or fluid cow's milk), parental smoking, and exposure to household pets4. Potential for reverse causality due to baseline atopic disease risk status impacting both the timing and types and amounts of CFB introduced, and risk of developing atopic disease.
Choose an application
The identification of the cause of an epileptic seizure is a key element in the clinical management of all patients. In recent decades, advances in theory, neuroimaging, molecular genetics and molecular chemistry have revolutionized our ability to investigate and identify the underlying cause. The definitive and unrivalled textbook on the causes of epilepsy, this second edition is extensively revised and expanded. It provides concise descriptions of all the major genetic and acquired conditions that cause epilepsy in adults and children, and the provoking factors for epileptic seizures and of the causes of status epilepticus. A new section considers clinical approaches to diagnosing causes, to guide and assist clinicians in investigations. With 128 chapters written by leading figures from around the world, this comprehensive and authoritative resource is indispensable to senior and junior clinicians and trainees working in the field of epilepsy, including specialists in neurology, paediatrics, neurophysiology, psychiatry and neurosurgery.
Choose an application
BACKGROUND: 1. Complementary feeding is the process that starts when human milk or infant formula is complemented by other foods and beverages, beginning during infancy and typically continuing to 24 months of age.2. This systematic review was conducted by a team of Nutrition Evidence Systematic Review (NESR) staff as part of the U.S. Department of Agriculture and Department of Health and Human Services Pregnancy and Birth to 24 Months Project.3. The goal of this systematic review was to answer the following research question: What is the relationship between timing of introduction of complementary foods/beverages and food allergy, atopic dermatitis/eczema, asthma, and allergic rhinitis? CONCLUSION STATEMENT AND GRADES: 1. Moderate evidence suggests that there is no relationship between the age at which complementary feeding first begins and risk of developing food allergy, atopic dermatitis/eczema, or asthma during childhood. Grade: Moderate2. There is insufficient evidence to determine the relationship between the age at which complementary foods or beverages are first introduced and risk of developing allergic rhinitis during childhood. Grade: Grade Not Assignable METHODS: 1. This systematic review was conducted by a team of staff from NESR in collaboration with a Technical Expert Collaborative.2. A literature search was conducted using 4 databases (CINAHL, Cochrane, Embase, and PubMed) to identify articles published from January 1980 to February 2017 that examined the age when complementary foods and beverages (CFB) were first introduced and food allergy, atopic dermatitis/eczema, asthma, and allergic rhinitis. CFB were defined as foods and beverages other than human milk or infant formula provided to an infant or young child. Outcomes included incidence and prevalence of food allergy, atopic dermatitis/eczema, asthma, and allergic rhinitis. A manual search was done to identify articles that may not have been included in the electronic databases searched. Articles were screened in a dual manner, independently by 2 NESR analysts, to determine which articles met predetermined criteria for inclusion.3. Data from each included article were extracted, risk of bias was assessed. The body of evidence was qualitatively synthesized, a conclusion statement was developed and the strength of the evidence (grade) was assessed using pre-established criteria including evaluation of the internal validity/risk of bias, adequacy, consistency, impact, and generalizability of available evidence. Research recommendations were identified. SUMMARY OF EVIDENCE: 1. Thirty-one observational studies are included in this systematic review, having examined the relationship between the age of first introduction to a CFB and risk of food allergies, atopic dermatitis/eczema, asthma, and allergic rhinitis occurring during childhood through 18 years of age. ○ The studies included in this review examined the timing of introduction to CFB, or the age at which infants were first introduced to any foods or beverages other than human milk or infant formula were first introduced to an infant. (Note: Studies that examined the timing of introduction of specific types of CFB, including common allergenic foods, such as peanuts, eggs, and fish, are addressed in a separate review).○ These studies did not specify what food or beverage was first introduced. However, highly allergenic foods are not typically the first CFB introduced into an infant's diet; therefore, it is likely that the studies in this body of evidence reflect the first introduction of cereals, fruits, and vegetables.○ Nine studies examined risk of food allergy, 20 studies examined risk of eczema or atopic dermatitis, eight studies examined risk of asthma, and four studies examined risk of allergic rhinitis.2. Most evidence reported no significant associations between age of CFB introduction and risk of food allergy. While some evidence suggested that earlier first introduction of CFB may be associated with increased risk of developing food allergy, confidence in the results was restricted by methodological limitations.3. The ability to draw stronger conclusions about the relationship between the timing of first introduction to CFB and the risk of atopic disease is due to several limitations: ○ Use of non-validated or unreliable measures to assess risk of atopic disease (e.g., parent report of a physician diagnosis or the child's symptoms), and assessment of outcomes later in childhood (through 10 years of age), when some atopic diseases, such as eczema, may have already resolved, or very early in childhood (3-4 months), before some atopic diseases may have occurred.○ Lack of adjustment for key confounders such as consumption of human milk and/or human milk substitutes (e.g., cow's milk formula, hydrolyzed infant formula, or fluid cow's milk), parental smoking, and exposure to household pets4. Potential for reverse causality due to baseline atopic disease risk status impacting both the timing and types and amounts of CFB introduced, and risk of developing atopic disease.
Choose an application
Choose an application
Evolutionary psychology. --- Mental illness --- Psychiatry --- Etiology. --- Philosophy.
Choose an application
Oxidative stress --- Diseases --- Cancer --- Pathophysiology. --- Etiology.
Choose an application
Mental Fatigue --- Mental Fatigue --- etiology. --- physiopathology.
Choose an application
Macrophages --- Neoplasms --- Neoplasms --- immunology. --- etiology. --- immunology.
Choose an application
Low Back Pain --- Low Back Pain --- etiology. --- epidemiology.
Choose an application
Neoplasms --- Neoplasms --- Neoplasms --- Cancer --- Cancer --- genetics. --- physiopathology. --- etiology. --- Génétique. --- Étiologie.
Listing 1 - 10 of 34 | << page >> |
Sort by
|